(Corsee) Sanders Corazon - 22 Jun 2022 Form 4 Insider Report for BeiGene, Ltd. (BGNE)

Role: Director
Signature: /s/ Qing Nian, as Attorney-in-Fact
Issuer symbol: BGNE
Transactions as of: 22 Jun 2022
Net transactions value: $0
Form type: 4
Filing time: 24 Jun 2022, 17:37:38 UTC
Previous filing: 06 Jun 2022
Next filing: 29 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BGNE	Ordinary Shares	Award	$0	+16,692	+214%	$0.000000	24,492	22 Jun 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BGNE	Share Option (Right to Buy)	Award	$0	+34,645		$0.000000	34,645	22 Jun 2022	Ordinary Shares	34,645	$11.98	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents securities underlying restricted share units. The restricted share units shall become fully vested on the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the director resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The restricted share unites were granted under the Company's Independent Director Compensation Policy, as amended.
F2	The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 Ordinary Shares.
F3	The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The option was granted under the Company's Independent Director Compensation Policy, as amended.